Esketamine nasal spray, FDA-approved since 2019 for treatment-resistant depression - taken in our clinic, under a doctor's supervision, with your progress measured at every visit.
Fewer than two trials? The screener will say "not yet" - and the doctor letter makes your next prescription count toward qualifying.
Quick symptom measures and blood pressure. Same nurse, same questions, so change is visible week to week.
You administer the nasal spray yourself, with the clinician right there. No IVs, no needles.
A comfortable chair, dim light if you want it, vitals checked on schedule. Doze, listen to music, or just be.
Someone you trust drives you home. No driving until the next day, after a night's sleep.
With commercial insurance, the manufacturer's savings program can bring your cost to as little as $10 per treatment. (By law it can't be combined with Medicaid, Medicare, or TRICARE - for those plans we work the coverage directly, and patient costs are typically minimal.)
Whatever your plan, you get your exact numbers in writing before your first treatment. No surprise bills. Ever.
The screener routes you honestly - clinic, at-home, or “not yet.”
Start the 2-minute screener